New biomarkers for the diagnosis of primary central nervous system lymphoma in CSF: A multicenter retrospective cohort study
We identified a panel of novel potential diagnostic markers in CSF for the diagnosis of PCNSL and confirmed the value of several known markers. The diagnostic value of these markers will be validated in a multicenter prospective study.
Authors
- Josephus van Rooij (ORCID: https://orcid.org/0000-0001-9715-5655)
- Peter H. Wessels (ORCID: https://orcid.org/0000-0002-7467-453X)
- Eveline M. Delemarre (ORCID: https://orcid.org/0000-0002-4310-0998)
- Tatjana Seute (ORCID: https://orcid.org/0000-0002-3668-6177)
- Tom J. Snijders (ORCID: https://orcid.org/0000-0003-0857-081X)
- Monique C. Minnema (ORCID: https://orcid.org/0000-0002-3139-8379)
- Bob Meek (ORCID: https://orcid.org/0000-0003-3410-9912)
- Stefan Nierkens (ORCID: https://orcid.org/0000-0003-3406-817X)
- Henk J.T. Ruven
Institutions
- Utrecht University (NL)
- University Medical Center Utrecht (NL)
- St. Antonius Ziekenhuis (NL)
- Princess Máxima Center (NL)
- Center for Translational Molecular Medicine (NL)
Publication Details
- Journal
- Neuro-Oncology Advances
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1093/noajnl/vdaf208
- Primary Topic
- CNS Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00